Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Conclusions Patients with CASR mutations may not fit the classic clinical pictures of hypercalcemia with hypocalciuria or hypocalcemia with hypercalciuria.
|
30407919 |
2019 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Based on this analysis, we suspected a hereditary form of hypocalcaemia and performed genetic testing by polymerase chain reaction and Sanger sequencing of the coding regions and intron boundaries of the CaSR gene.
|
28741586 |
2017 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Autosomal dominant hypocalcaemia (ADH) is caused by activating mutations in the calcium sensing receptor gene (CaR) and characterised by mostly asymptomatic mild to moderate hypocalcaemia with low, inappropriately serum concentration of PTH.
|
25766501 |
2015 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
These studies of a mouse model with an activating CaSR mutation demonstrate NPS 2143 to normalize the gain-of-function causing ADH1 and improve the hypocalcemia associated with this disorder.
|
26052899 |
2015 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Activating calcium-sensing receptor gene variants in children: a case study of infant hypocalcaemia and literature review.
|
25039540 |
2014 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
We also postulated that mutations effecting Gα11 gain of function, like the mutations effecting calcium-sensing receptor gain of function that cause autosomal dominant hypocalcemia type 1, may lead to hypocalcemia.
|
23802516 |
2013 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
To describe a case of hypocalcemia in a patient with a gain-of-function mutation in the calcium-sensing receptor that was undetected until adulthood and successfully treated with recombinant parathyroid hormone.
|
23186954 |
2013 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Activating mutations of the calcium-sensing receptor (CASR) gene are associated with autosomal dominant hypocalcemia (ADH) characterized by benign hypocalcemia, inappropriately low (PTH) levels and mostly hypercalciuria.
|
23009664 |
2013 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Persistent hypocalcaemia in a Chinese girl due to a novel de-novo activating mutation of the calcium-sensing receptor gene.
|
21471599 |
2011 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Naturally occurring mutations in the calcium-sensing receptor gene (CASR) cause hypocalcaemia or hypercalcaemia, and molecular diagnosis of these mutations is clinically important.
|
17320849 |
2007 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
The gain of function mutations of the calcium-sensing receptor are associated with autosomal dominant hypocalcaemia (ADH), a disease characterised by a generally asymptomatic hypocalcaemia, inappropriately high urinary calcium excretion and normal PTH levels.
|
17039419 |
2006 |
Hypocalcemia
|
0.500 |
AlteredExpression
|
phenotype |
LHGDN |
A case of gain-of-function mutation in calcium-sensing receptor: supplemental hydration is required for renal protection.
|
15960151 |
2005 |
Hypocalcemia
|
0.500 |
Biomarker
|
phenotype |
BEFREE |
The extracellular calcium-sensing receptor (CaSR) plays a pivotal role in the regulation of extracellular calcium such that abnormalities, which result in a loss or gain of function, lead to hypercalcemia or hypocalcemia, respectively, in patients.
|
15347804 |
2004 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.
|
12733714 |
2003 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Gain-of-function mutations of the calcium-sensing receptor (CaR) gene cause autosomal dominant and/or sporadic hypocalcemia with hypercalciuria.
|
12107202 |
2002 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
LHGDN |
A family of autosomal dominant hypocalcemia with a positive correlation between serum calcium and magnesium: identification of a novel gain of function mutation (Ser(820)Phe) in the calcium-sensing receptor.
|
12050233 |
2002 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Hypocalcemia segregated with the CaR mutation, but no phenotype-genotype relationships were identified.
|
11701698 |
2001 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
We experienced two patients (proband and her daughter) with hypocalcemia caused by a missense mutation of the CaSR gene.
|
11289719 |
2001 |
Hypocalcemia
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Activating mutations of the calcium-sensing receptor: management of hypocalcemia.
|
11701698 |
2001 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Inherited abnormalities of the CASR gene located on chromosome 3p13.3-21 can cause either hypercalcemia or hypocalcemia depending upon whether they are inactivating or activating, respectively.
|
11013439 |
2000 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Mutations of the CASR gene alter the set-point for extracellular ionised calcium [Ca2+]o and cause familial hypercalcaemia or hypocalcaemia.
|
10023897 |
1999 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Among 11 missense mutations of CaSR reported to date in patients with ADH or sporadic hypocalcemia, functional properties of 8 mutant CaSRs were characterized.
|
9920108 |
1999 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
In addition, gain of function CaSR mutations have been observed in a novel familial syndrome of hypocalcaemia with hypercalciuria.
|
9920407 |
1998 |
Hypocalcemia
|
0.500 |
GeneticVariation
|
phenotype |
BEFREE |
Gain-of-function mutations in the calcium-sensing receptor are associated with a familial syndrome of hypocalcemia with hypercalciuria that needs to be distinguished from hypoparathyroidism.
|
8813042 |
1996 |
Hypocalcemia
|
0.500 |
Biomarker
|
phenotype |
CTD_human |
Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation.
|
7874174 |
1994 |